This morning the Federal Circuit released one precedential opinion and one nonprecedential order. The precedential opinion comes in a patent case and vacates a judgment of invalidity based on ineligibility. The nonprecedential order is a dismissal. Here is the introduction to the opinion and a link to the order.
Astellas Pharma, Inc. v. Sandoz Inc. (Precedential)
Astellas Pharma, Inc., Astellas Ireland Co., Ltd., and Astellas Pharma Global Development, Inc. (collectively, “Astellas”) appeal from the final judgment of the United States District Court for the District of Delaware. Following a five-day bench trial on issues of infringement and validity under 35 U.S.C. § 112, the district court determined, sua sponte, that claims 5, 20, and 25 of U.S. Patent 10,842,780 (“the ’780 patent”) are invalid under 35 U.S.C. § 101 as directed to an ineligible natural law. Astellas Pharma Inc. v. Sandoz Inc., No. 20-cv-1589, 2023 WL 3934386 (D. Del. June 9, 2023) (“Decision”). For the reasons set forth below, we vacate the judgment and remand.